List of Active ICON Protocols
1.
A Phase II
study of Gemcitabine as 4 hour infusion with carboplatin in inoperable stage III
and IV NSCLC (Protocol No: ICON/ LUNG/ 0105)
Status:
2.
Comprehensive
Management for patients with Chronic Myeloid Leukemia (Protocol TMC/CML/MO-0401;
Version Date 20 April 2004) – a phase II feasibility and tolerability study.
Status: Ongoing
3.
Combination
Chemotherapy for MM (Protocol No: ICON/Hematol-MM/0306) Status: Ongoing
4.
A phase II b RCT
of Neo adjuvant chemotherapy comparing Paclitaxel, Ifosfamide and Cisplatin with
Paclitaxel, Cisplatin and 5-FU in patients with locally advanced head & neck
cancer. (Protocol No: ICON/H&N/0601)
Status:
Ongoing
5.
An open label,
multicentre phase I/II dose escalating study of Pablocan (NPB001-05) in patients
of chronic myeloid leukemia who have demonstrated resistance / intolerance to
the local prevailing standard of care.(Protocol No: ICON/CML/0701) Status:
Ongoing
6.
An
Observational Study of Pegylated Liposomal Doxorubicin and Carboplatin in
Patients with Platinum Sensitive Epithelial Relapsed Ovarian Cancer. (Protocol
No: ICON/Ovary/0703)
Status:
Ongoing
7.
A Phase II
Open-Label Study of the Subcutaneous Administration of Homoharringtonine
(Omacetaxine) (CGX-635) in the Treatment of Patients with
Chronic Myeloid Leukemia (CML) Who have Failed or Are Intolerant to Tyrosine
Kinase Inhibitor Therapy (Protocol No. CGX-635-CML-203) Status: Ongoing
8.
A Phase II
Open-Label Study of the Subcutaneous Administration of Homoharringtonine
(Omacetaxine) (CGX-635) in the Treatment of Patients with Chronic Myeloid
Leukemia (CML) with the T315I BCR-ABL Gene Mutation (Protocol No.
CGX-635-CML-202) Status: Ongoing
9. Neo-Adjuvant Docetaxel +
Platinum for Locally Advanced Breast Cancer: A single arm observational
study (ICON/LABC/0108)
Status:
proposed